Director Peribere makes first open-market purchase of 1,210 shares after prior stock-comp-only activity; stock trades well below 52-week highs as company maintains profitability.
Peribere Jerome A, a director at Xylem, deployed personal capital to purchase shares on the open market for the first time in at least three years—a shift from his prior activity, which consisted solely of stock-based compensation transactions. The timing aligns with the stock trading meaningfully below its 52-week high and down over recent quarters, effectively allowing him to add to his stake at reduced prices. Xylem remains a profitable, revenue-growing company, so this purchase is into a fundamentally sound business rather than a turnaround situation. As a first open-market buy, this transaction breaks his historical pattern and suggests a decision to increase direct exposure beyond what his compensation package alone would provide.